M Fisher

Summary

Country: UK

Publications

  1. doi request reprint Cardiovascular safety of albiglutide in the Harmony programme: a meta-analysis
    Miles Fisher
    Department of Diabetes and Endocrinology, Glasgow Royal Infirmary, Glasgow, UK Electronic address
    Lancet Diabetes Endocrinol 3:697-703. 2015
  2. doi request reprint Improving cardiovascular risk--applying evidence-based medicine to glucose-lowering therapy with thiazolidinediones in patients with type 2 diabetes
    M Fisher
    Glasgow Royal Infirmary, Glasgow, UK
    Int J Clin Pract 63:1354-68. 2009
  3. ncbi request reprint Oral antidiabetic agents as cardiovascular drugs
    D P Macfarlane
    Diabetes Centre, Glasgow Royal Infirmary, Glasgow, UK
    Diabetes Obes Metab 9:23-30. 2007
  4. doi request reprint Cardiovascular drugs as antidiabetic agents: evidence for the prevention of type 2 diabetes
    D P Macfarlane
    Diabetes Centre, Glasgow Royal Infirmary, Glasgow, UK
    Diabetes Obes Metab 10:533-44. 2008
  5. pmc Diabetes: can we stop the time bomb?
    M Fisher
    Glasgow Royal Infirmary, Glasgow G31 2ER, UK
    Heart 89:ii28-30; discussion ii35-7. 2003
  6. ncbi request reprint Normoglycaemia in acute renal failure--a difficult diagnosis of diabetes
    B Mukhopadhyay
    Department of Diabetes, Glasgow Royal Infirmary, Glasgow
    Scott Med J 50:127-8. 2005

Collaborators

Detail Information

Publications6

  1. doi request reprint Cardiovascular safety of albiglutide in the Harmony programme: a meta-analysis
    Miles Fisher
    Department of Diabetes and Endocrinology, Glasgow Royal Infirmary, Glasgow, UK Electronic address
    Lancet Diabetes Endocrinol 3:697-703. 2015
    ..We did a prospective meta-analysis of the cardiovascular safety of albiglutide as stipulated by the US Food and Drug Administration recommendations for the assessment of new treatments for diabetes...
  2. doi request reprint Improving cardiovascular risk--applying evidence-based medicine to glucose-lowering therapy with thiazolidinediones in patients with type 2 diabetes
    M Fisher
    Glasgow Royal Infirmary, Glasgow, UK
    Int J Clin Pract 63:1354-68. 2009
    ..The thiazolidinediones are equally effective in improving glycaemic control when used in combination regimens in patients with type 2 diabetes, but have differing effects on the diabetic dyslipidaemia...
  3. ncbi request reprint Oral antidiabetic agents as cardiovascular drugs
    D P Macfarlane
    Diabetes Centre, Glasgow Royal Infirmary, Glasgow, UK
    Diabetes Obes Metab 9:23-30. 2007
    ..The results of further long-term cardiovascular outcome studies with these newer agents are awaited...
  4. doi request reprint Cardiovascular drugs as antidiabetic agents: evidence for the prevention of type 2 diabetes
    D P Macfarlane
    Diabetes Centre, Glasgow Royal Infirmary, Glasgow, UK
    Diabetes Obes Metab 10:533-44. 2008
    ..With current guidelines, the use of cardiovascular drugs modifying the RAS will increase in at-risk individuals, but at present, they cannot be recommended to prevent diabetes...
  5. pmc Diabetes: can we stop the time bomb?
    M Fisher
    Glasgow Royal Infirmary, Glasgow G31 2ER, UK
    Heart 89:ii28-30; discussion ii35-7. 2003
    ..The challenge now is for all health care professionals to implement the treatment guidelines...
  6. ncbi request reprint Normoglycaemia in acute renal failure--a difficult diagnosis of diabetes
    B Mukhopadhyay
    Department of Diabetes, Glasgow Royal Infirmary, Glasgow
    Scott Med J 50:127-8. 2005
    ..In a patient with undiagnosed diabetes mellitus presenting with acute on chronic renal failure, choice of diagnostic biochemical test for diabetes may be difficult...